1 active not recruiting, 1 completed, 1 unknown. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Active not recruiting 1, Completed 1, Unknown 1 |
Follow ART: new trials by email Literature Review of ART trials Research Report on ART
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Accelerated ART Initiation for PWHIV Who Are Out of Care The Accelerate model of care, bictegravir/emtricitabine/tenofovir alafenamide 50/200/25 mg - HIV Infections, ART | Phase 4 | Active not recruiting | University of Missouri-Columbia | 120 | 2024-04-29 | 2026-08-05 |
| Investigating the Interaction Between Two Long-acting Reversible Methods of Contraception and Dolutegravir, a Treatment for HIV Dolutegravir, Levonorgestrel implant, Depo medroxyprogesterone acetate injection - Human Immunodeficiency Virus, Contraception | Phase 4 | Unknown | Botswana Harvard AIDS Institute Partnership | 140 | 2021-10-21 | 2023-07-27 |
| Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM Biktarvy - ART, HIV | Phase 4 | Completed | Emory University | 20 | 2019-09-30 | 2022-02-22 |
Acquired Immunodeficiency Syndrome (1) · HIV Infections (1) · Patient Compliance (1)
Blood-Borne Infections (2) · Communicable Diseases (2) · Genital Diseases (2) · Immune System Diseases (2) · Immunologic Deficiency Syndromes (2) · Infections (2) · Lentivirus Infections (2) · RNA Virus Infections (2) · Retroviridae Infections (2) · Sexually Transmitted Diseases (2) · Sexually Transmitted Diseases, Viral (2) · Urogenital Diseases (2) · Virus Diseases (2) · Behavior (1) · HIV Infections (1)
Emtricitabine (1) · Levonorgestrel (1) · Medroxyprogesterone Acetate (1) · bictegravir (1) · bictegravir, emtricitabine, tenofovir alafenamide, drug combination (1) · dolutegravir (1) · tenofovir alafenamide (1)
Botswana Harvard AIDS Institute Partnership (1) · Emory University (1) · University of Missouri-Columbia (1)
United States (2) · Botswana (1)
Chelsea Morroni, PhD MBChB (1) · Colleen Kelley, MD (1) · Dima Dandachi, MD, MPH (1)